BioStem Technologies (OTCMKTS:BSEM) Trading 5.1% Higher – Here’s What Happened

BioStem Technologies, Inc. (OTCMKTS:BSEM) was up 5.1% on Friday . The stock traded as high as $5.89 and last traded at $5.80. Approximately 29,118 shares traded hands during trading, a decline of 85% from the average daily volume of 193,572 shares. The stock had previously closed at $5.52.

BioStem Technologies Stock Up 5.1%

The business has a fifty day simple moving average of $4.96 and a 200-day simple moving average of $5.54. The firm has a market cap of $97.55 million, a P/E ratio of 6.82 and a beta of -0.38.

BioStem Technologies (OTCMKTS:BSEM) last posted its quarterly earnings data on Thursday, November 13th. The company reported $0.03 EPS for the quarter, topping the consensus estimate of $0.02 by $0.01. The business had revenue of $10.47 million for the quarter, compared to the consensus estimate of $55.20 million. On average, sell-side analysts anticipate that BioStem Technologies, Inc. will post 1.41 EPS for the current fiscal year.

BioStem Technologies Company Profile

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr.